A
ISSUER//CIK 0001008848
Acorda Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K1.1 MBAcorda Therapeutics, Inc.Aug 9, 9:06 AM ET·0000950170-24-094382
- 8-K89.9 MBAcorda Therapeutics, Inc.Jul 22, 8:16 PM ET·0000950170-24-085405
- 8-K163.0 KBAcorda Therapeutics, Inc.Jul 11, 4:53 PM ET·0000950170-24-082994
- 8-K91.3 MBAcorda Therapeutics, Inc.Jun 24, 5:54 PM ET·0000950170-24-076941
- 8-K153.8 KBAcorda Therapeutics, Inc.Jun 12, 4:44 PM ET·0000950170-24-072511
- 8-K155.1 KBAcorda Therapeutics, Inc.Jun 4, 4:40 PM ET·0000950170-24-068750
- 8-K98.2 MBAcorda Therapeutics, Inc.May 24, 8:24 AM ET·0000950170-24-064311
- 10-Q6.6 MBAcorda Therapeutics, Inc.May 14, 8:24 AM ET·0000950170-24-059114
- 10-K/A1.1 MBAcorda Therapeutics, Inc.Apr 29, 8:39 AM ET·0000950170-24-049448
- 8-K149.9 KBAcorda Therapeutics, Inc.Apr 25, 8:00 PM ET·0000950170-24-048583
Insiders
10- BAB BIO VENTURES NV10% Owner
- Batycky Richard P.Chief Tech. Off. & Site Head
- BB BIOVENTURES L P10% Owner
- Belloff Neil S.General Counsel and Corp Secy
- BLANK BURKHARDCMO and Head of R&D
- Blight AndrewChief Scientific Officer
- BURNS THOMAS M.Director
- Carrazana Enrique J.Chief Medical Officer
- Clem Kerry MChief Commercial Officer
- COHEN RONDirector, President and CEO
Tickers
No tickers on record
Addresses
business
TWO BLUE HILL PLAZA
PEARL RIVER, NY, 10965
mailing
TWO BLUE HILL PLAZA
PEARL RIVER, NY, 10965
Former Names
- ACORDA THERAPEUTICS INC2023-03-15